Li Ma

Nintedanib enhances the efficacy of PD-L1 blockade by upregulating MHC-I and PD-L1 expression in tumor cells

Jingyao Tu, Haoran Xu, Li Ma et al. · Theranostics · 2021 · 74 citations · Full text

Medicine, Oncology, Pharmacology +17

Resveratrol inhibits the phosphatidylinositide 3-kinase/protein kinase B/mammalian target of rapamycin signaling pathway in the human chronic myeloid leukemia K562 cell line

Tao Sui, Li Ma, Xue Bai et al. · Oncology Letters · 2014 · 33 citations · Full text

Medicine, Oncology, Pharmacology +16

[A multicenter, double-blind, placebo-controlled, randomized, phase III clinical study of etanercept in treatment of ankylosing spondylitis].

Feng Huang, Jie Zhang, Jian-lin Huang et al. · PubMed · 2010 · 15 citations

Medicine, Internal Medicine, Pharmacotherapy +14

CircSCUBE3 Reduces the Anti-gastric Cancer Activity of Anti-PD-L1

Hu-Sheng Shan, Xiaobo Zhang, Xiao Zhang et al. · Molecular Biotechnology · 2023 · 12 citations

Medicine, Cancer Biology, Oncology +10

Semaphorin 3A-hypoxia inducible factor 1 subunit alpha co-overexpression enhances the osteogenic differentiation of induced pluripotent stem cells-derived mesenchymal stem cells in vitro

Jingyi Li, Tingting Wang, Chong Li et al. · Chinese Medical Journal · 2020 · 11 citations · Full text

Engineering, Bioengineering, Biotechnology +17